D. Western Therapeutics Institute (TSE:4576) Shares Outstanding (Basic Average): 47.93 Mil (As of Dec. 2025)


TSE:4576 D. Western Therapeutics Institute Inc TSE:4576
50 GF Score
Price 円69.00
GF Value 円64.35
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is D. Western Therapeutics Institute Shares Outstanding (Basic Average)?

D. Western Therapeutics Institute TSE:4576 -1.43% 50 Shares Outstanding (Basic Average) is 47.93 Mil as of Dec. 2025. GuruFocus rates TSE:4576 with a GF Score™ of 50/100 and a GF Value™ of 円64.35 (Fairly Valued). The stock has 3 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. D. Western Therapeutics Institute's average basic shares outstanding for the quarter that ended in Dec. 2025 was 47.93 Mil.


D. Western Therapeutics Institute  (TSE:4576) Shares Outstanding (Basic Average) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.


Be Aware

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


D. Western Therapeutics Institute Shares Outstanding (Basic Average) Related Terms


D. Western Therapeutics Institute Shares Outstanding (Basic Average) Historical Data

* Premium members only.

The historical data trend for D. Western Therapeutics Institute's Shares Outstanding (Basic Average) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

D. Western Therapeutics Institute Shares Outstanding (Basic Average) Chart

D. Western Therapeutics Institute Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (Basic Average)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.33 29.64 31.78 35.12 47.93

D. Western Therapeutics Institute Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
Shares Outstanding (Basic Average) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.12 43.99 44.76 47.93 54.40
TSE:4576
50GF Score
D. Western Therapeutics Institute Inc TSE:4576
Shares Outstanding (Basic Average) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

D. Western Therapeutics Institute Shares Outstanding (Basic Average) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (Basic Average) of 47.93 Mil mean?
D. Western Therapeutics Institute (TSE:4576) has a Shares Outstanding (Basic Average) of 47.93 Mil as of Dec. 2025. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on D. Western Therapeutics Institute and its competitors.
Is D. Western Therapeutics Institute's Shares Outstanding (Basic Average) too high?
D. Western Therapeutics Institute's current Shares Outstanding (Basic Average) is 47.93 Mil. Overall, D. Western Therapeutics Institute has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does D. Western Therapeutics Institute's Shares Outstanding (Basic Average) compare to VRTX and REGN?
D. Western Therapeutics Institute's Shares Outstanding (Basic Average) of 47.93 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (Basic Average) for a Biotechnology company?
A good Shares Outstanding (Basic Average) depends on the Biotechnology industry context. However, Shares Outstanding (Basic Average) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (Basic Average) mean?
A high Shares Outstanding (Basic Average) can signal that a stock is expensive relative to its fundamentals. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on D. Western Therapeutics Institute and its competitors. D. Western Therapeutics Institute's current Shares Outstanding (Basic Average) is 47.93 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is D. Western Therapeutics Institute stock overvalued right now?
Based on GuruFocus' analysis, D. Western Therapeutics Institute (TSE:4576) is currently considered Fairly Valued. The stock's GF Value™ is 円64.35, compared to a current price of 円69.00 — trading 7.2% above its estimated fair value. The current Shares Outstanding (Basic Average) is 47.93 Mil. D. Western Therapeutics Institute's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (Basic Average) calculated?
Shares Outstanding (Basic Average) is calculated from a company's financial statements. For D. Western Therapeutics Institute (TSE:4576), the current Shares Outstanding (Basic Average) is 47.93 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is D. Western Therapeutics Institute (TSE:4576) Overvalued in 2026?

Based on GuruFocus' analysis, D. Western Therapeutics Institute stock appears to be overvalued. The current stock price of 円69.00 is trading 7.2% above its estimated GF Value™ of 円64.35. GuruFocus considers D. Western Therapeutics Institute to be Fairly Valued.

Key valuation signals for TSE:4576:

  • Shares Outstanding (Basic Average): 47.93 Mil
  • GF Value™: 円64.35 vs. price of 円69.00 (7.2% above fair value)
  • GF Score™: 50/100 with 3 warning signs

No single metric tells the full story. See the TSE:4576 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


D. Western Therapeutics Institute Business Description

Other Exchanges 6DW:Germany
Address 7th Floor, 18 KT Bulding, 1-18-11, Nishiki, Naka-ku, Aichi, Nagoyashi, JPN, 460-0003
D. Western Therapeutics Institute Inc is engaged in the research and development of pharmaceutical drugs in Japan. Its products include ophthalmic solution and agents for antiplatelet and anti-glaucoma.
50GF Score

Get the complete analysis for TSE:4576

Shares Outstanding (Basic Average) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円69.00
Price
円64.35
GF Value